Jefferies Sticks to Their Sell Rating for Alkem Laboratories Ltd. (ALKEM)
Jefferies analyst Alok Dalal maintained a Sell rating on Alkem Laboratories Ltd. (ALKEM – Research Report) on May 30 and set a price target of INR4,460.00. The company's shares closed last Friday at INR5,098.50.
Confident Investing Starts Here:
According to TipRanks, Dalal is a 2-star analyst with an average return of 2.0% and a 50.00% success rate. Dalal covers the Healthcare sector, focusing on stocks such as Ajanta Pharma Limited, Alkem Laboratories Ltd., and Cipla Ltd.
Currently, the analyst consensus on Alkem Laboratories Ltd. is a Moderate Sell with an average price target of INR4,947.50.
Based on Alkem Laboratories Ltd.'s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of INR30.32 billion and a net profit of INR5.45 billion. In comparison, last year the company earned a revenue of INR29.68 billion and had a net profit of INR2.87 billion
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Jefferies downgrades Chewy on valuation concerns, sees limited upside
-- Jefferies downgraded Chewy Inc (NYSE:CHWY) to 'Hold' from 'Buy' citing stretched valuation after a 41% rally in the stock this year and limited room for near-term earnings upside. Chewy shares are now trading at 24 times its 2026 EBITDA forecast, about eight turns above where they were in March and one standard deviation above historical averages , a level that implies strong Q1 results and guidance raises, which Jefferies thinks are unlikely. 'The pet macro looks relatively stable, and Chewy is executing well,' analysts wrote, but added that most of the positives appear priced in. Those positives include improved alternative data signals, such as rising web traffic and app usage, as well as stronger revenue from sponsored ads. Chewy is expected to benefit from supply chain efficiencies and increased advertising from pet product manufacturers. App data from SensorTower showed a 7.6% year-over-year increase in users and a 24% rise in downloads. Web traffic is also trending up, according to SimilarWeb (NYSE:SMWB). Still, Jefferies pointed to a lack of macro catalysts, such as growth in new pet-owning households, and said recent U.S. consumer data suggests only modest increases in pet spending, potentially limiting upside in the near term. The firm expects Chewy to reiterate or slightly raise the low end of its full-year guidance, but sees little justification for raising estimates beyond that. Jefferies slightly lifted its 2025 revenue forecast to $12.44 billion and EBITDA to $700 million, near the top of management's guide. The price target was cut to $43 from $45, based on 20 times estimated 2027 EBITDA. Related articles Jefferies downgrades Chewy on valuation concerns, sees limited upside HSBC upgrades Dr Reddy's on weight loss drug semaglutide-driven earnings rebound Wall Street weighs in as Apple bid to halt app store order denied
Yahoo
4 hours ago
- Yahoo
Netflix (NFLX) Hits Record High as Jefferies Lifts Price Target to $1,400
Netflix (NFLX, Financials) climbed to a record intraday high Tuesday before closing just below $1,218, after Jefferies raised its price target to $1,400. The new target implies a 15% upside from Tuesdays close and stands well above the $1,192 consensus. Warning! GuruFocus has detected 7 Warning Sign with COST. List of 52-Week Lows List of 3-Year Lows List of 5-Year Lows Jefferies reiterated its "buy" rating, pointing to sustained earnings growth, a robust 2025 content lineup, and accelerating ad revenue. The firm said Netflix could maintain annual earnings per share growth of over 20% and projected advertising income to reach as much as $10 billion by 2030. New episodes of Squid Game, Stranger Things, and Wednesday are expected to help Netflix retain subscribers while capitalizing on price hikes and its ongoing crackdown on password sharing. Jefferies said Netflix may also benefit from expanding into live sports and entertainment, further strengthening its position in a crowded streaming market. Shares have gained nearly 37% year to date, significantly outperforming the S&P 500s sub-2% rise. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 hours ago
- Yahoo
Analysts Add NVIDIA (NVDA) to Top Buy List, Cite AI Strength and Blackwell Chip Upside
We recently published a list of . In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands against other trending AI stocks on Wall Street right now. On June 3rd, Jefferies added six new names to its list of 'highest-conviction, Buy-rated' stocks, including chip giant NVIDIA Corporation (NASDAQ:NVDA). The firm sees upside to the chipmaker's full year 2025 guidance from its Blackwell Ultra chips and strength in networking. 'Ramp of Blackwell should push (gross margin %) to mid-70% throughout the year.' A close-up of a colorful high-end graphics card being plugged in to a gaming computer. The firm views Nvidia as a dominant supplier of AI accelerators within the data center, coming away impressed with the company's quarterly results. The highlight was particularly its revenue projection that largely mirrored what analysts expected despite the impact from U.S. export curbs. This revenue optimism largely comes from the 'massive step up' in AI commitments from Saudi Arabia and the United Arab Emirates. 'We view NVDA as the dominant supplier of AI accelerators within the data center, an industry that is expanding rapidly due to the development and adoption of AI.' NVIDIA specializes in AI-driven solutions, offering platforms for data centers, self-driving cars, robotics, and cloud services. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
